Literature DB >> 338319

Transport of prostaglandins across the blood-brain and blood-aqueous barriers and the physiological significance of these absorptive transport processes.

L Z Bito, M C Wallenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 338319     DOI: 10.1016/s0014-4835(77)80020-1

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  8 in total

1.  Anisocoria in unilateral ophthalmic disease.

Authors:  R V Pearson; G E Rose
Journal:  Br J Ophthalmol       Date:  1991-01       Impact factor: 4.638

Review 2.  Vitreous anatomy and the vitreomacular correlation.

Authors:  Shoji Kishi
Journal:  Jpn J Ophthalmol       Date:  2016-05-10       Impact factor: 2.447

3.  Effect of probenecid on breathing movements and cerebral clearance of prostaglandin E2 in fetal sheep.

Authors:  D W Walker; N Pratt
Journal:  J Physiol       Date:  1998-01-01       Impact factor: 5.182

4.  Endotoxin-induced uveitis in the rat. A study of the role of inflammation mediators.

Authors:  C P Herbort; A Okumura; M Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 5.  Immunological concepts and the eye: a review of the classical and ocular arthus reactions.

Authors:  L D Ormerod
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

6.  Subthreshold argon-laser irradiation elicits a pronounced vitreal prostaglandin E2 response.

Authors:  N Naveh; E Bartov; C Weissman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT).

Authors:  R Lu; N Kanai; Y Bao; V L Schuster
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

8.  Localisation of prostaglandin F2 alpha and E2 binding sites in the human eye.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.